Reuters logo
in 3 months
BRIEF-Pharma Mar says Aplidin gets orphan drug status to treat multiple myeloma in Switzerland
May 4, 2017 / 8:09 AM / in 3 months

BRIEF-Pharma Mar says Aplidin gets orphan drug status to treat multiple myeloma in Switzerland

1 Min Read

May 4 (Reuters) - Pharma Mar SA:

* Aplidin receives orphan drug status for the treatment of multiple myeloma in Switzerland

* The company submitted the Marketing Authorisation Application in the European Union at the end of 2016 Source text: bit.ly/2p8zftX

Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below